Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Vanda Pharma Q2 EPS $(0.46) Misses $(0.36) Estimate, Sales $52.59M Miss $54.60M Estimate

Author: Benzinga Newsdesk | July 31, 2025 06:36am
Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.36) by 28.85 percent. This is a 475 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $52.59 million which missed the analyst consensus estimate of $54.60 million by 3.68 percent. This is a 4.19 percent increase over sales of $50.47 million the same period last year.

Posted In: VNDA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist